Targeted cancer	Sponsor	Trial number	Vaccine type (vaccine name*)	Vaccine development phase
				Phase 1	Phase 2	Phase 3
Brain	Guangdong 999 Brain Hospital	NCT02808416	Personalised mRNA cellular vaccine (PerCellVac3)	Ongoing
Breast or melanoma	Inge Marie Svane	NCT00978913	mRNA transfected dendritic cell vaccine	Ongoing
General	National Cancer Institute	NCT03480152	Personalised mRNA vaccine (NCI‐4650)	Ongoing	Ongoing
Melanoma	ModernaTX	NCT03897881	Personalised mRNA vaccine (mRNA‐4157)	Completed	Ongoing
Oesophageal and/or non‐small cell lung	Stemirna Therapeutics	NCT03908671	Personalised mRNA vaccine	Ongoing
	Ludwig Institute for Cancer Research	NCT03164772	mRNA vaccine (BI 1361849)	Ongoing	Ongoing
Ovarian	University Medical Center Groningen	NCT04163094	mRNA vaccine (W_ova1)	Ongoing
	Oslo University Hospital	EUCTR2010‐020233‐56‐NO	mRNA transfected dendritic cell vaccine	Ongoing	Ongoing
	Steinar Aamdal	NCT01334047	Personalised mRNA transfected dendritic cell vaccine (DC‐006)	Ongoing	Ongoing
Prostate	Center for Cancer Immunotherapy and Department of Oncology, Herlev Hospital	EUCTR2011‐001602‐10‐DK	mRNA transfected dendritic cell vaccine (Taxotere)	Completed	Ongoing
	Oslo University Hospital	NCT01278914	mRNA transfected dendritic cell vaccine	Ongoing	Ongoing
	Oslo University Hospital	NCT01197625	mRNA transfected dendritic cell vaccine (DC‐005)	Ongoing	Ongoing
	Oslo University Hospital	EUCTR2010‐018770‐20‐NO	Personalised mRNA transfected dendritic cell vaccine	Ongoing	Ongoing
	University of Florida	NCT01153113	Personalised mRNA transfected dendritic cell vaccine (hTERT mRNA DC)	Completed	Ongoing
Solid tumours	Stemirna Therapeutics	ChiCTR1900023000	Personalised mRNA vaccine	Ongoing
	University Hospital, Antwerp	NCT01291420	Personalised mRNA transfected dendritic cell vaccine	Ongoing	Ongoing

mRNA = messenger RNA.

^*If available.